CompaniesBetaGlue Therapeutics
BetaGlue Therapeutics logo

BetaGlue Therapeutics

active
Milan, Italy
Founded 2018
Website
About

Radiotherapy

Areas of Focus

Categories

Drug Delivery DeviceRadiopharmaceuticals
Team (20)
Alexis Peyroles MBA
Alexis Peyroles MBA
Chief Executive Officer (CEO)
BetaGlue Therapeutics
executive
Diana Saraceni
Diana Saraceni
Investor Director (Panakès)
BetaGlue Therapeutics
team_member
Dr. Carol Hegarty
Dr. Carol Hegarty
Clinical Operations Manager
BetaGlue Therapeutics
team_member
Dr. Gianluca De Danieli MD, MSc
Dr. Gianluca De Danieli MD, MSc
Head of Clinical Development
BetaGlue Therapeutics
team_member
Dr. Michel Therin DVM, PhD
Dr. Michel Therin DVM, PhD
Independent Non-Executive Director
BetaGlue Therapeutics
team_member
Dr. Pieter Janssen
Dr. Pieter Janssen
Head of Product Development
BetaGlue Therapeutics
team_member
View all 20 team members →
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

10

By Phase

NA: 1

By Status

NOT_YET_RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2025
2026
2027
2028
Today
NCT07155850
Hover over trial bars to see details

Recent Trials

NCT07155850Lead Sponsor
Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC
NANot yet recruiting
10 participants
Started: Jan 31, 2026 · Completed: Feb 28, 2027
Locations (1)
Headquarters
Milan, Italy
Map

Loading map...